Wells Pharma of Houston LLC recalls ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Ph
Recalled December 13, 2023 · FDA recall D-0141-2024 · Wells Pharma of Houston
Hazard
Lack of assurance of sterility. · FDA Class II
Units
825 syringes
Sold at
Philadelphia, Pennsylvania.
Description
Lack of assurance of sterility.
Product
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
Manufacturer(s)
Wells Pharma of Houston LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →